BIOMAT Database Logo BIOMAT Database Logo

[Efavirenz and nevirapine plasma levels in HIV-infected patients with hemophilia]. 2005

Marta Martorell, and Rosa M López, and Esteban Ribera, and Isabel Ruiz, and Cristina Tural, and Lluís Puig, and Josep Monterde
Unidad de Hemofilia, Servicio de Farmacia, Hospital Universitario Vall d'Hebron, Barcelona, Spain. mmartore@vhebron.net

The aim of this study was to evaluate efavirenz and nevirapine plasma levels in HIV-infected hemophilic patients seen in two hospitals in Barcelona. Plasma levels of these drugs were determined by high-performance liquid chromatography (HPLC) at four-month intervals, together with viral load and CD4 cell count. Nineteen patients treated with efavirenz and 8 with nevirapine were included, and 68 efavirenz and 31 nevirapine determinations were performed. Mean study time was 12 months. Median efavirenz plasma concentration was 2.95 .g/ml (interval: 1.54-5.26 .g/ml) in patients with favorable virological response and 1.86 .g/ml (0.82-4.88 .g/ml) in patients with detectable viral load (p = 0.32). Nevirapine plasma concentrations were 4.41 .g/ml (3.50-6.72 .g/ml) and 3.12 .g/ml (2.44-3.80 .g/ml) respectively (p = 0.18).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D005260 Female Females
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000480 Alkynes Hydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2. Acetylenic Compounds,Alkyne,Acetylenes
D000963 Antimetabolites Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) Antimetabolite

Related Publications

Marta Martorell, and Rosa M López, and Esteban Ribera, and Isabel Ruiz, and Cristina Tural, and Lluís Puig, and Josep Monterde
[Rashes in HIV-infected patients undergoing therapy with nevirapine or efavirenz].
September 2005, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
Marta Martorell, and Rosa M López, and Esteban Ribera, and Isabel Ruiz, and Cristina Tural, and Lluís Puig, and Josep Monterde
Comparison of efavirenz and nevirapine in HIV-infected patients (NEEF Cohort).
June 2005, International journal of STD & AIDS,
Marta Martorell, and Rosa M López, and Esteban Ribera, and Isabel Ruiz, and Cristina Tural, and Lluís Puig, and Josep Monterde
Nevirapine + efavirenz based salvage therapy in heavily pretreated HIV infected patients.
February 2002, Sexually transmitted infections,
Marta Martorell, and Rosa M López, and Esteban Ribera, and Isabel Ruiz, and Cristina Tural, and Lluís Puig, and Josep Monterde
Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients.
January 2005, Pharmacogenetics and genomics,
Marta Martorell, and Rosa M López, and Esteban Ribera, and Isabel Ruiz, and Cristina Tural, and Lluís Puig, and Josep Monterde
Efavirenz to nevirapine switch in HIV-1-infected patients with dyslipidemia: a randomized, controlled study.
July 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Marta Martorell, and Rosa M López, and Esteban Ribera, and Isabel Ruiz, and Cristina Tural, and Lluís Puig, and Josep Monterde
Plasma concentrations of efavirenz and nevirapine among HIV-infected patients with immunological failure attending a tertiary hospital in North-western Tanzania.
January 2013, PloS one,
Marta Martorell, and Rosa M López, and Esteban Ribera, and Isabel Ruiz, and Cristina Tural, and Lluís Puig, and Josep Monterde
Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults.
March 2010, AIDS research and therapy,
Marta Martorell, and Rosa M López, and Esteban Ribera, and Isabel Ruiz, and Cristina Tural, and Lluís Puig, and Josep Monterde
Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.
April 2013, The Lancet. Infectious diseases,
Marta Martorell, and Rosa M López, and Esteban Ribera, and Isabel Ruiz, and Cristina Tural, and Lluís Puig, and Josep Monterde
Treatment of HIV-infected patients with a combination of efavirenz, nevirapine and nucleoside reverse transcriptase inhibitors.
March 2004, HIV medicine,
Marta Martorell, and Rosa M López, and Esteban Ribera, and Isabel Ruiz, and Cristina Tural, and Lluís Puig, and Josep Monterde
Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients.
July 2006, European journal of clinical pharmacology,
Copied contents to your clipboard!